请输入您要查询的百科知识：

　

词条 RPN2
释义

  1. Function

  2. Structure

      Gene    Protein  

  3. Function

  4. Clinical significance

  5. Interactions

  6. Model organisms

  7. References

  8. Further reading

{{Infobox gene}}Dolichyl-diphosphooligosaccharide—protein glycosyltransferase subunit 2, also called ribophorin ǁ is an enzyme that in humans is encoded by the RPN2 gene.[1]

Function

This gene encodes a type I integral ribophorin membrane protein found only in the rough endoplasmic reticulum. The encoded protein is part of an N-oligosaccharyl transferase complex that links high mannose oligosaccharides to asparagine residues found in the Asn-X-Ser/Thr consensus motif of nascent polypeptide chains. This protein is similar in sequence to the yeast oligosaccharyl transferase subunit SWP1.[1] RPN2 has been demonstrated to be a prognostic marker of human cancer, and may be a potential target of clinical importance.

Structure

Gene

The RPN2 gene lies on the chromosome location of 20q11.23 and consists of 19 exons.

Protein

RPN2 consists of 631 amino acid residues and weighs 69284Da.

Function

RPN2 is a unique integral glycoprotein in rough ER membrane that is involved in translocation and the maintenance of the structural uniqueness of the rough ER. It is also an essential subunit of N-oligosaccharyl transferase complex that conjugates high mannose oligosaccharides to asparagine residues in the N-X-S/T consensus motif of nascent polypeptide chains.[2][3][4][5] RPN2 regulates the glycosylation of multi-drug resistance, and thus its interference could decrease the membrane localization of P-glycoprotein by reducing its glycosylation status and restored the sensitivity to docetaxel.[6]

Clinical significance

RPN2 has been demonstrated to be a prognostic marker of human cancer. RPN2 is highly expressed in breast cancer stem cells and is associated with tumor metastasis. Recent study has shown that its expression is correlated with clinically aggressive features of breast cancer, implying a possible application in personalized medicine.[7] RPN2 silencing has been reported to repress tumorigenicity and to sensitize the tumors to cisplatin treatment, which led to the longer survival of NSCLC-bearing mice, suggesting that RPN2 may represent a promising new target for RNAi-based medicine against NSCLC.[6] Similar potential application has also been shown in osteosarcoma, esophageal squamous cell carcinoma and colorectal cancer.[8][9][10] RPN2 is also reported to be one of the prothrombin-binding proteins on monocyte surfaces, suggesting that its involvement in the pathophysiology of thrombosis in patients with APS.[11]

Interactions

P53 [7]tetraspanin CD63 [12]

prothrombin [11]

Model organisms

Model organisms have been used in the study of RPN2 function. A conditional knockout mouse line, called Rpn2tm1a(EUCOMM)Wtsi[17][18] was generated as part of the International Knockout Mouse Consortium program — a high-throughput mutagenesis project to generate and distribute animal models of disease to interested scientists.[19][20][21]

Male and female animals underwent a standardized phenotypic screen to determine the effects of deletion.[15][22] Twenty six tests were carried out on mutant mice and two significant abnormalities were observed.[15] No homozygous mutant embryos were identified during gestation, and therefore none survived until weaning. The remaining tests were carried out on heterozygous mutant adult mice; no additional significant abnormalities were observed in these animals.[15]

References

1. ^1 {{cite web | title = Entrez Gene: RPN2 ribophorin II| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6185| accessdate = }}
2. ^{{cite journal | vauthors = Kelleher DJ, Kreibich G, Gilmore R | title = Oligosaccharyltransferase activity is associated with a protein complex composed of ribophorins I and II and a 48 kd protein | journal = Cell | volume = 69 | issue = 1 | pages = 55–65 | date = April 1992 | pmid = 1555242 | doi=10.1016/0092-8674(92)90118-v}}
3. ^{{cite journal | vauthors = Kelleher DJ, Gilmore R | title = An evolving view of the eukaryotic oligosaccharyltransferase | journal = Glycobiology | volume = 16 | issue = 4 | pages = 47R-62R | date = April 2006 | pmid = 16317064 | doi = 10.1093/glycob/cwj066 }}
4. ^{{cite journal | vauthors = Crimaudo C, Hortsch M, Gausepohl H, Meyer DI | title = Human ribophorins I and II: the primary structure and membrane topology of two highly conserved rough endoplasmic reticulum-specific glycoproteins | journal = The EMBO Journal | volume = 6 | issue = 1 | pages = 75–82 | date = January 1987 | pmid = 3034581 | pmc = 553359 }}
5. ^{{cite journal | vauthors = Yuan TM, Liang RY, Chueh PJ, Chuang SM | title = Role of ribophorin II in the response to anticancer drugs in gastric cancer cell lines | journal = Oncology Letters | volume = 9 | issue = 4 | pages = 1861–1868 | date = April 2015 | pmid = 25789057 | pmc = 4356382 | doi = 10.3892/ol.2015.2900 }}
6. ^1 {{cite journal | vauthors = Fujita Y, Yagishita S, Takeshita F, Yamamoto Y, Kuwano K, Ochiya T | title = Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer | journal = Oncotarget | volume = 6 | issue = 5 | pages = 3335–45 | date = February 2015 | pmid = 25595901 | pmc = 4413657 | doi = 10.18632/oncotarget.2793 }}
7. ^1 {{cite journal | vauthors = Ono M, Tsuda H, Kobayashi T, Takeshita F, Takahashi RU, Tamura K, Akashi-Tanaka S, Moriya T, Yamasaki T, Kinoshita T, Yamamoto J, Fujiwara Y, Ochiya T | title = The expression and clinical significance of ribophorin II (RPN2) in human breast cancer | journal = Pathology International | volume = 65 | issue = 6 | pages = 301–8 | date = June 2015 | pmid = 25881688 | doi = 10.1111/pin.12297 }}
8. ^{{cite journal | vauthors = Fujiwara T, Takahashi RU, Kosaka N, Nezu Y, Kawai A, Ozaki T, Ochiya T | title = RPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis | journal = Molecular Therapy. Nucleic Acids | volume = 3 | pages = e189 | date = September 2014 | pmid = 25181275 | pmc = 4222647 | doi = 10.1038/mtna.2014.35 }}
9. ^{{cite journal | vauthors = Kurashige J, Watanabe M, Iwatsuki M, Kinoshita K, Saito S, Nagai Y, Ishimoto T, Baba Y, Mimori K, Baba H | title = RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma | journal = British Journal of Cancer | volume = 107 | issue = 8 | pages = 1233–8 | date = October 2012 | pmid = 22955852 | pmc = 3494434 | doi = 10.1038/bjc.2012.396 }}
10. ^{{cite journal | vauthors = Zhang J, Yan B, Späth SS, Qun H, Cornelius S, Guan D, Shao J, Hagiwara K, Van Waes C, Chen Z, Su X, Bi Y | title = Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer | journal = Cell & Bioscience | volume = 5 | pages = 53 | date = 2015-01-01 | pmid = 26388988 | pmc = 4574027 | doi = 10.1186/s13578-015-0043-9 }}
11. ^1 {{cite journal | vauthors = Fujieda Y, Amengual O, Matsumoto M, Kuroki K, Takahashi H, Kono M, Kurita T, Otomo K, Kato M, Oku K, Bohgaki T, Horita T, Yasuda S, Maenaka K, Hatakeyama S, Nakayama KI, Atsumi T | title = Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes | journal = Rheumatology | volume = 55 | issue = 6 | pages = 1117–26 | date = June 2016 | pmid = 26895716 | doi = 10.1093/rheumatology/kew005 }}
12. ^{{cite journal | vauthors = Tominaga N, Hagiwara K, Kosaka N, Honma K, Nakagama H, Ochiya T | title = RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy | journal = Molecular Cancer | volume = 13 | pages = 134 | date = May 2014 | pmid = 24884960 | pmc = 4070641 | doi = 10.1186/1476-4598-13-134 }}
13. ^{{cite web |url=http://www.sanger.ac.uk/mouseportal/phenotyping/MBEJ/salmonella-challenge/ |title=Salmonella infection data for Rpn2 |publisher=Wellcome Trust Sanger Institute}}
14. ^{{cite web |url=http://www.sanger.ac.uk/mouseportal/phenotyping/MBEJ/citrobacter-challenge/ |title=Citrobacter infection data for Rpn2 |publisher=Wellcome Trust Sanger Institute}}
15. ^1 2 3 {{cite journal | doi = 10.1111/j.1755-3768.2010.4142.x | title = The Sanger Mouse Genetics Programme: High throughput characterisation of knockout mice | year = 2010 | author = Gerdin AK | journal = Acta Ophthalmologica | volume = 88 | pages = 925–7 }}
16. ^Mouse Resources Portal, Wellcome Trust Sanger Institute.
17. ^{{cite web |url=http://www.knockoutmouse.org/martsearch/search?query=Rpn2 |title=International Knockout Mouse Consortium}}
18. ^{{cite web |url=http://www.informatics.jax.org/searchtool/Search.do?query=MGI:4432779 |title=Mouse Genome Informatics}}
19. ^{{cite journal | vauthors = Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, Mujica AO, Thomas M, Harrow J, Cox T, Jackson D, Severin J, Biggs P, Fu J, Nefedov M, de Jong PJ, Stewart AF, Bradley A | title = A conditional knockout resource for the genome-wide study of mouse gene function | journal = Nature | volume = 474 | issue = 7351 | pages = 337–42 | date = June 2011 | pmid = 21677750 | pmc = 3572410 | doi = 10.1038/nature10163 }}
20. ^{{cite journal | vauthors = Dolgin E | title = Mouse library set to be knockout | journal = Nature | volume = 474 | issue = 7351 | pages = 262–3 | date = June 2011 | pmid = 21677718 | doi = 10.1038/474262a }}
21. ^{{cite journal | vauthors = Collins FS, Rossant J, Wurst W | title = A mouse for all reasons | journal = Cell | volume = 128 | issue = 1 | pages = 9–13 | date = January 2007 | pmid = 17218247 | doi = 10.1016/j.cell.2006.12.018 }}
22. ^{{cite journal | vauthors = van der Weyden L, White JK, Adams DJ, Logan DW | title = The mouse genetics toolkit: revealing function and mechanism | journal = Genome Biology | volume = 12 | issue = 6 | pages = 224 | date = June 2011 | pmid = 21722353 | pmc = 3218837 | doi = 10.1186/gb-2011-12-6-224 }}

Further reading

{{refbegin|33em}}
  • {{cite journal | vauthors = Stoffel M, Xiang K, Bell GI | title = Dinucleotide repeat polymorphism at the human ribophorin II locus (RPN2) on chromosome 20q | journal = Human Molecular Genetics | volume = 1 | issue = 8 | pages = 656 | date = November 1992 | pmid = 1301181 | doi = 10.1093/hmg/1.8.656 }}
  • {{cite journal | vauthors = Löffler C, Rao VV, Hansmann I | title = Mapping of the ribophorin II (RPN II) gene to human chromosome 20q12-q13.1 by in-situ hybridization | journal = Human Genetics | volume = 87 | issue = 2 | pages = 221–2 | date = June 1991 | pmid = 2066112 | doi = 10.1007/BF00204188 }}
  • {{cite journal | vauthors = Kumar V, Heinemann FS, Ozols J | title = Interleukin-2 induces N-glycosylation in T-cells: characterization of human lymphocyte oligosaccharyltransferase | journal = Biochemical and Biophysical Research Communications | volume = 247 | issue = 2 | pages = 524–9 | date = June 1998 | pmid = 9642163 | doi = 10.1006/bbrc.1998.8780 }}
  • {{cite journal | vauthors = Fu J, Kreibich G | title = Retention of subunits of the oligosaccharyltransferase complex in the endoplasmic reticulum | journal = The Journal of Biological Chemistry | volume = 275 | issue = 6 | pages = 3984–90 | date = February 2000 | pmid = 10660554 | doi = 10.1074/jbc.275.6.3984 }}
  • {{cite journal | vauthors = Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J | title = Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides | journal = Nature Biotechnology | volume = 21 | issue = 5 | pages = 566–9 | date = May 2003 | pmid = 12665801 | doi = 10.1038/nbt810 }}
  • {{cite journal | vauthors = Kelleher DJ, Karaoglu D, Mandon EC, Gilmore R | title = Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties | journal = Molecular Cell | volume = 12 | issue = 1 | pages = 101–11 | date = July 2003 | pmid = 12887896 | doi = 10.1016/S1097-2765(03)00243-0 }}
  • {{cite journal | vauthors = Shibatani T, David LL, McCormack AL, Frueh K, Skach WR | title = Proteomic analysis of mammalian oligosaccharyltransferase reveals multiple subcomplexes that contain Sec61, TRAP, and two potential new subunits | journal = Biochemistry | volume = 44 | issue = 16 | pages = 5982–92 | date = April 2005 | pmid = 15835887 | doi = 10.1021/bi047328f }}
  • {{cite journal | vauthors = Tu LC, Yan X, Hood L, Lin B | title = Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells | journal = Molecular & Cellular Proteomics | volume = 6 | issue = 4 | pages = 575–88 | date = April 2007 | pmid = 17220478 | doi = 10.1074/mcp.M600249-MCP200 }}
{{refend}}{{Use dmy dates|date=April 2017}}

1 : Genes mutated in mice
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/11/13 19:30:07